Insight Molecular Diagnostics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $65.2M | $32.9M |
| FY2022 | — | $34.3M | $20.0M |
| FY2023 | — | $20.5M | $9.4M |
| FY2024 | — | $-12.3M | $8.6M |
| FY2025 | — | $-31.5M | $11.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $65.2M | $32.9M |
| FY2022 | — | $34.3M | $20.0M |
| FY2023 | — | $20.5M | $9.4M |
| FY2024 | — | $-12.3M | $8.6M |
| FY2025 | — | $-31.5M | $11.6M |